Infection Prevention and Control
The Food and Drug Administration Friday authorized for emergency use a real-time polymerase chain reaction test to detect mpox (formerly known as monkeypox) in lesion swab specimens from individuals whose health care provider suspects they have the virus
The Society for Healthcare Epidemiology, in collaboration with AHA and other organizations, yesterday published updated best practices for hospitals to prevent healthcare-associated infections through hand hygiene based on the latest evidence.
The CDC released a dashboard tracking hospitalization rates for laboratory-confirmed COVID-19, flu and Respiratory Syncytial Virus by age group, sex, race/ethnicity, state and season based on data from select counties in 13 states, which the agency will update weekly.
The Centers for Disease Control and Prevention joined the government of Uganda and global public health community in marking the end of the Ebola outbreak in Uganda, 42 days after the last reported case.
U.S. clinicians should consider cholera in patients with acute diarrhea returning from countries with cholera transmission, the Centers for Disease Control and Prevention said in an advisory yesterday, citing eight cases this year in travelers returning to the United States.
The CDC reported continued increases in certain health care-associated infections in 2021 and improvements in others, based on the summary measure used by the National Healthcare Safety Network to track these infections.
The Ebola outbreak in Uganda has not spread to the United States or other countries to date, the CDC said in an update to clinicians.
Black, Hispanic and American Indian/Alaska Native adults have higher flu hospitalization rates and lower flu vaccination rates than white adults, according to a report released by the CDC.
The Biden Administration released a strategy to better prepare and protect the nation from future pandemics and biological threats, and called for Congress to provide $88 billion over five years to help implement the plan.
During the COVID-19 public health emergency, CMS will continue to exercise enforcement discretion under the Clinical Laboratory Improvement Amendments to allow providers to test asymptomatic individuals using certain point-of-care SARS-CoV-2 tests authorized for symptomatic individuals, CMS…